Theo Wargo/Getty
- Citron Research says marijuana company Cronos is worth one-third of its current value.
- Specifically, Citron says Cronos has duped investors by excluding key information from disclosures.
- Cronos fell as much as 10% following the note.
- Follow Cronos in real time here.
Citron Research — a short-selling firm with a history of wiping out stock prices and run by Andrew Left — has a new target: cannabis stocks.
In a report published Thursday, the firm says Cronos, one of the most valuable publicly traded marijuana companies, is worth roughly one-third of its current price: $3.50 per share.
See the rest of the story at Business Insider
NOW WATCH: INSIDE WEST POINT: What it’s really like for new Army cadets on their first day
See Also:
- Your opinion matters — Join BI Insiders program
- We shopped at Dollar Tree and Dollar General to see which offered a better shopping experience, and the winner was obvious
- All the TV shows that have been canceled in 2018
SEE ALSO: Legal marijuana could be worth $47 billion in the US alone, according to a Wall Street analyst
from Feedburner https://ift.tt/2C2xtpN
No comments:
Post a Comment